IDEXX Laboratories, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.14B | 1.09B | 1.11B | 1.11B | 998.4M | 954.3M | 975.5M | 1.00B |
| Cost of Goods Sold | 418.1M | 432.5M | 421.9M | 414.7M | 375.0M | 383.6M | 379.5M | 382.7M |
| Gross Profit | 722.7M | 658.1M | 683.4M | 694.7M | 623.4M | 570.7M | 596.0M | 620.9M |
| R&D Expenses | 65.8M | 66.8M | 63.4M | 61.9M | 59.1M | 57.7M | 54.0M | 55.5M |
| Operating Expenses | 360.2M | 342.5M | 328.5M | 321.7M | 306.8M | 309.0M | 292.1M | 355.4M |
| Operating Income | 362.6M | 315.6M | 354.8M | 373.0M | 316.5M | 261.7M | 303.9M | 263.8M |
| Other Income / Gains | -7.1M | -8.6M | -10.1M | -10.7M | -6.5M | -5.3M | -5.0M | -4.7M |
| Net Income | 278.4M | 248.2M | 274.6M | 294.0M | 242.7M | 216.1M | 232.8M | 203.3M |
| EPS (Diluted) | 3.48 | 3.10 | 3.43 | 3.66 | 2.98 | 2.63 | 2.83 | 2.46 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.634 | 0.603 | 0.618 | 0.626 | 0.624 | 0.598 | 0.611 | 0.619 |
| General And Administrative Expenses | 119.1M | 108.6M | 105.9M | 98.7M | 91.6M | 101.1M | 91.9M | 157.2M |
| Selling And Marketing Expenses | 175.3M | 167.1M | 159.2M | 161.1M | 156.2M | 150.1M | 146.3M | 142.7M |
| Selling General And Administrative Expenses | 294.4M | 275.7M | 265.1M | 259.8M | 247.8M | 251.2M | 238.2M | 299.9M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 778.2M | 775.0M | 750.4M | 736.4M | 681.9M | 692.6M | 671.7M | 739.8M |
| Interest Income | 0 | 587K | 580K | 627K | 1.2M | 2.2M | 2.7M | 3.4M |
| Interest Expense | 7.1M | 10.5M | 10.7M | 11.3M | 7.7M | 7.5M | 7.7M | 8.1M |
| Depreciation And Amortization | 0 | 38.7M | 36.6M | 35.8M | 34.1M | 33.7M | 34.1M | 32.2M |
| Ebitda | 362.6M | 356.2M | 392.1M | 409.4M | 351.8M | 298.6M | 342.0M | 300.7M |
| Ebitdaratio | 0.318 | 0.327 | 0.355 | 0.369 | 0.352 | 0.313 | 0.351 | 0.30 |
| Operating Income Ratio | 0.318 | 0.289 | 0.321 | 0.336 | 0.317 | 0.274 | 0.312 | 0.263 |
| Income Before Tax | 355.4M | 307.0M | 344.8M | 362.4M | 310.1M | 256.4M | 298.9M | 259.1M |
| Income Before Tax Ratio | 0.312 | 0.281 | 0.312 | 0.327 | 0.311 | 0.269 | 0.306 | 0.258 |
| Income Tax Expense | 77.0M | 58.8M | 70.2M | 68.4M | 67.4M | 40.2M | 66.1M | 55.8M |
| Net Income Ratio | 0.244 | 0.228 | 0.248 | 0.265 | 0.243 | 0.227 | 0.239 | 0.203 |
| Epsdiluted | 3.45 | 3.08 | 3.40 | 3.63 | 2.96 | 2.62 | 2.80 | 2.44 |
| Weighted Average Shs Out | 80.1M | 80.1M | 80.1M | 80.4M | 81.3M | 81.8M | 82.3M | 82.6M |
| Weighted Average Shs Out Dil | 80.7M | 80.7M | 80.7M | 81.0M | 81.9M | 82.5M | 83.1M | 83.4M |